These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28651451)

  • 1. Incidence of unprovoked venous thromboembolic events in patients with chronic lymphocytic leukemia.
    Katkish LA; Rangaraju S; Rector TS; Gravely AA; Johnson GJ; Klein MA; Gupta P
    Leuk Lymphoma; 2018 Feb; 59(2):509-511. PubMed ID: 28651451
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic lymphocytic leukaemia is a risk factor for venous thromboembolism.
    Whittle AM; Allsup DJ; Bailey JR
    Leuk Res; 2011 Mar; 35(3):419-21. PubMed ID: 21156322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment.
    Antic D; Jelicic J; Vukovic V; Nikolovski S; Mihaljevic B
    Blood Rev; 2018 Mar; 32(2):144-158. PubMed ID: 29126566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
    Goyal G; Bhatt VR
    Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients with chronic lymphocytic leukemia.
    Šimkovič M; Vodárek P; Motyčková M; Belada D; Vrbacký F; Žák P; Smolej L
    Thromb Res; 2015 Dec; 136(6):1082-6. PubMed ID: 26467608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?
    Chua CC; Lim HY; Tacey M; Nandurkar H; Ho P
    Eur J Haematol; 2017 Jul; 99(1):18-26. PubMed ID: 28321922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in cancer patients: risk assessment, prevention and management.
    Tukaye DN; Brink H; Baliga R
    Future Cardiol; 2016 Mar; 12(2):221-35. PubMed ID: 26919091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients.
    Yoon L; Clarke Hillyer G; Chen L; Hu JC; Neugut AI; Hershman DL; Wright JD
    Cancer Invest; 2016 Sep; 34(8):408-14. PubMed ID: 27624740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of chronic lymphocytic leukemia: analysis of 203 cases in China.
    Wu T; Li ZJ; Qiu LG
    Leuk Res; 2010 Feb; 34(2):e64-5. PubMed ID: 19699521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recurrent venous thromboembolic events--a prospective study].
    Munteanu I; Munteanu I
    Pneumologia; 2012; 61(4):214-20. PubMed ID: 23424945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of venous thromboembolism in the cancer surgical patient.
    Kakkar AK
    J Clin Oncol; 2009 Oct; 27(29):4881-4. PubMed ID: 19738112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is venous thromboembolism a problem in patients with cancer in palliative care?
    Sandset PM; Dahm AEA
    Lancet Haematol; 2019 Feb; 6(2):e61-e62. PubMed ID: 30709433
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization.
    Hohaus S; Tisi MC; Bartolomei F; Cuccaro A; Maiolo E; Alma E; D'Alò F; Bellesi S; Rossi E; De Stefano V
    Blood Cancer J; 2018 Jun; 8(6):54. PubMed ID: 29884791
    [No Abstract]   [Full Text] [Related]  

  • 14. Update in venous thromboembolism pathophysiology, diagnosis, and treatment for surgical patients.
    Coleman DM; Obi A; Henke PK
    Curr Probl Surg; 2015 Jun; 52(6):233-59. PubMed ID: 26071037
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.
    Napolitano M; Valore L; Malato A; Saccullo G; Vetro C; Mitra ME; Fabbiano F; Mannina D; Casuccio A; Lucchesi A; Del Principe MI; Candoni A; Di Raimondo F; Siragusa S
    Leuk Lymphoma; 2016; 57(1):116-9. PubMed ID: 25944377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in inflammatory bowel disease: an epidemiological review.
    Murthy SK; Nguyen GC
    Am J Gastroenterol; 2011 Apr; 106(4):713-8. PubMed ID: 21407182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
    Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
    J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism: From bench to bedside.
    Key NS; Moll S
    Thromb Res; 2009; 123 Suppl 4():S1. PubMed ID: 19303495
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimising VTE in patients with cancer.
    Watson J
    Nurs Times; 2016 Feb 24-Mar 1; 112(8):18-21. PubMed ID: 27071239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult cancer screening and idiopathic venous thromboembolic disease: Where do we stand?
    Yannoutsos A; Lazareth I; Priollet P
    J Med Vasc; 2018 Dec; 43(6):339-341. PubMed ID: 30522704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.